Hilberg, Frank,Hofmann, Marco Hans,Reschke, Markus,Solca, Flavio
申请号：
AU2018277227
公开号：
AU2018277227A1
申请日:
2018.06.01
申请国别(地区):
AU
年份:
2019
代理人:
摘要：
The invention relates to the combined use of certain bispecific, VEGF and Ang2 binding molecules with PD1 antagonists for the treatment of cancer. It further relates to pharmaceutical compositions and kits comprising such binding molecules and antagonists.
